Dolca Thomas

Insider Reports History

Entity
Individual
Location
C/O Principia Biopharma Inc., 220 E. Grand Avenue, South San Francisco, California
Signature
/s/ H. Baird Radford, III, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dolca Thomas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allakos Inc. Director Stock Option (Right to buy) 41K May 24, 2024 Direct
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct

Insider Reports Filed by Dolca Thomas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLK Allakos Inc. May 24, 2024 1 $0 4 May 29, 2024 Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 4 -$1.08M 4 Aug 11, 2023 Director
ALLK Allakos Inc. Aug 1, 2023 1 $0 4 Aug 3, 2023 Director
ALLK Allakos Inc. Jul 31, 2023 0 $0 3 Aug 3, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2023 2 $0 4 May 31, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Sep 2, 2022 2 $212K 4 Sep 6, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2022 2 $0 4 May 31, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director